Revisiting the role of postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a propensity score matching analysis
Jia-Jun Li, Ye Xu, Hua-Hua Liu, Mao-Pei Chen, Yi Chen, Ning-Ling Ge, Lan Zhang, Zheng-Gang Ren, Xin-Rong Yang, Rong-Xin Chen · 2025
Read Revisiting the role of postoperative adjuvant transarterial chemoembolization in hepatocellular carcinoma: a propensity score matching analysis by Jia-Jun Li, Ye Xu, Hua-Hua Liu, Mao-Pei Chen, Yi Chen, Ning-Ling Ge, Lan Zhang, Zheng-Gang Ren, Xin-Rong Yang, Rong-Xin Chen (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12780597.txt.
Description
After liver cancer surgery, doctors disagree on whether extra treatment helps keep the cancer away. Jia-Jun Li and co-authors revisit one option, a procedure, PA-TACE, that delivers chemotherapy via the liver's artery after the tumor is removed. They compared about four hundred patients who did or did not receive it, and used matching to make the groups more alike. Both recurrence free survival and overall survival were tracked.
Patients who received the procedure lived longer, and their edge in staying recurrence free was borderline at first but clear after matching. The clearest benefit sat in patients whose tumors had invaded blood vessels: in that group the procedure cut recurrence risk by about two thirds and death risk by over half. Patients who did recur after the procedure had less aggressive tumors. The authors conclude the added treatment helps most patients with vessel invasion.
Catalog record
| CREATOR | Jia-Jun Li, Ye Xu, Hua-Hua Liu, Mao-Pei Chen, Yi Chen, Ning-Ling Ge, Lan Zhang, Zheng-Gang Ren, Xin-Rong Yang, Rong-Xin Chen |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 33 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |